porfiromycin has been researched along with Leukemia L 1210 in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| BOSTWICK, L; EVANS, JS; MENGEL, GD | 1 |
| Bradner, WT; Iyengar, BS; Remers, WA; Sami, SM; Schurig, JE | 1 |
| Bush, JA; Claridge, CA; Doyle, TW; Kammer, MF; Kimball, D; Moseley, JE; Nettleton, DE; Veitch, J | 1 |
| Driscoll, J; Goldin, A; Kojima, R; Mantel, N | 1 |
4 other study(ies) available for porfiromycin and Leukemia L 1210
| Article | Year |
|---|---|
SYNERGISM OF THE ANTINEOPLASTIC ACTIVITY OF CYTOSINE ARABINOSIDE BY PORFIROMYCIN.
Topics: Animals; Anti-Bacterial Agents; Antineoplastic Agents; Body Weight; Cytarabine; Cytosine; Leukemia; Leukemia L1210; Leukemia, Experimental; Mice; Mitomycin; Mitomycins; Neoplasms; Neoplasms, Experimental; Nucleosides; Pharmacology; Porfiromycin; Research; Survival | 1964 |
Mitomycin C and porfiromycin analogues with substituted ethylamines at position 7.
Topics: Animals; Ethylamines; Female; Leukemia L1210; Leukemia P388; Leukopenia; Melanoma; Mice; Mitomycins; Neoplasms, Experimental; Porfiromycin; Structure-Activity Relationship | 1983 |
New mitomycin analogs produced by directed biosynthesis.
Topics: Animals; Chemical Phenomena; Chemistry; Injections, Intraperitoneal; Leukemia L1210; Mice; Mice, Inbred DBA; Mitomycins; Porfiromycin; Stereoisomerism | 1986 |
Some structive-activity relationships for mitomycin C (NSC-26980) derivatives in the treatment of L1210 leukemia.
Topics: Acetamides; Alkylation; Amines; Animals; Azirines; Carbamates; Hydroxylation; Leukemia L1210; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Mitomycins; Porfiromycin; Prognosis; Structure-Activity Relationship | 1972 |